Illumina, Inc. Announces Purchase of HiSe(TM) 2000 Units by the Broad Institute
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) announced today that the Broad Institute has purchased 51 HiSeq 2000s, Illumina’s market leading high-throughput next-generation sequencing system. The HiSeq 2000s will replace an equal number of Genome AnalyzerIIx systems in the current installed base as the Broad upgrades and expands its sequencing capacity.